Belgian Biotech Starts Human Trials for a Potential Type 1 Diabetes Cure
Labiotech.eu (blog) Imcyse will run its first clinical trial testing a specific immunotherapy that could finally provide a cure to autoimmune diseases. Imcyse, a Belgian biotech spun out from the Katholieke Universiteit Leuven in 2010, just announced it has received ... |
Social Plugin